Stockreport

GILD Obtains Positive CHMP Opinion for Liver Disease Drug [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Agency's Committee for Medicinal Products for Human Use (CHMP) for its liver disease drug seladelpar, which is expected to be approved in the first quarter of 2025. The [Read more]